CSIMarket
 


Spotlight Innovation Inc.  (STLT)
Other Ticker:  
 

Cumulative Spotlight Innovation's Quick Ratio for Trailing Twelve Months Period

STLT's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

STLT Quick Ratio for Trailing Twelve Months Period

(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
Y / Y Current Liabilities Growth -2.38 % -60.08 % -58.47 % 27.77 % 34 %
Y / Y Cash & cash equivalent Growth -98.47 % -82.31 % -78.9 % -47.92 % 76.25 %
Quick Ratio for Trailing Twelve Months Period 0.02 0.03 0.04 0.04 0.05
Total Ranking # 4732 # 4793 # 4651 # 4131 # 3692
Seq. Current Liabilities Growth 24.36 % 2.66 % 1.35 % -24.55 % -49.15 %
Seq. Cash & cash equivalent Growth -95.08 % -40.11 % -56.11 % 17.85 % -42.9 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2018
On the trailing twelve months basis Despite year on year decrease in Spotlight Innovation's average Current Liabilities to $3 millions, Quick Ratio for Trailing Twelve Months Period to 0.02 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 88 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Spotlight Innovation. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about STLT
Quick Ratio STLT in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 89
Sector # 830
S&P 500 # 4853


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.12 0.05 0
(Mar 31 2016)   (Sep 30 2012)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2018, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Ds Healthcare Group, Inc.  0.05 
Zivo Bioscience Inc   0.04 
Glucose Health, Inc.  0.04 
Spotlight Innovation Inc.  0.03 
Genethera Inc   0.03 
Premier Biomedical Inc  0.02 
Mymetics Corporation  0.02 
Zeo Scientifix Inc   0.02 
Creative Medical Technology Holdings Inc   0.02 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com